DW Healthcare Partners Invests in LKC Technologies
June 6, 2023
DW Healthcare Partners, a healthcare-focused private equity firm, completed an investment in LKC Technologies, maker of the handheld RETeval electroretinography/visual evoked potential device. The transaction positions LKC to scale its diagnostic medical-device business globally under new CEO Dina Dubey as founder Jim Datovech transitions from the CEO role.
- Buyers
- DW Healthcare Partners
- Targets
- LKC Technologies, Inc.
- Industry
- Medical Devices
- Location
- Maryland, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
AMETEK Acquires LKC Technologies
February 8, 2026
Medical Devices
AMETEK, Inc. has acquired LKC Technologies, a Germantown, Maryland-based maker of portable ophthalmic diagnostic devices, including the RETeval handheld ERG system. The seller was DW Healthcare Partners, which had owned LKC as a portfolio company; AMETEK said the deal expands its ophthalmic product portfolio and complements its Ultra Precision Technologies Reichert business.
-
Carrick Capital Partners Invests in Renalogic (Growth Recapitalization)
March 3, 2021
Healthcare Services
Carrick Capital Partners has made a growth recapitalization investment in Renalogic, a provider of dialysis risk management and chronic kidney disease (CKD) cost-containment solutions. The investment will support Renalogic's expansion of services — including its predictive analytics/AI platform CareINSIGHTS.ai — to scale support for self-funded employers, health plans and stop-loss carriers.
-
LLR Partners Makes Growth Investment in TruTechnologies
May 28, 2025
Healthcare Services
LLR Partners has made a strategic growth investment in TruTechnologies, a provider of real-time clinical trial oversight and sample-management software. The capital will support TruTechnologies' product and commercial expansion; BofA served as exclusive financial advisor to TruTechnologies while Wachtell, Lipton, Rosen & Katz and DLA Piper served as legal advisors to the respective parties.
-
DFW Capital Partners Makes Strategic Investment in WorldCare Clinical
January 6, 2020
Healthcare Services
DFW Capital Partners completed a significant investment in WorldCare Clinical, a global imaging contract research organization (CRO). The deal will support WorldCare's growth and capability expansion while CEO Aaron Timm remains in place and two DFW operating partners join WorldCare's board.
-
JLL Partners Acquires Parks Medical Electronics and Combines It with Vascular Technology
November 6, 2025
Medical Devices
JLL Partners has acquired Parks Medical Electronics and merged the business with Vascular Technology to create a vascular diagnostics and robotics-focused medical device platform. The combination brings Parks Medical's Doppler ultrasound product line together with Vascular Technology's intraoperative systems to expand the combined company's product portfolio and clinical reach across hospital, clinic, operating room, and veterinary markets.
-
JLL Partners Invests in Vascular Technology, Incorporated
June 30, 2025
Medical Devices
JLL Partners, a New York-based middle market private equity firm, has announced an investment in Vascular Technology, Incorporated (VTI), a Nashua, New Hampshire-based medical device company that develops intraoperative Doppler systems and remote suction/irrigation solutions. As part of the transaction JLL partnered with entrepreneur Nilendu Srivastava and the VTI management team and appointed Greg Groenke as CEO and Lars Marcher as Executive Chairman to accelerate product development and market expansion.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.